Table 1.
Level | Presence of any one of these tests |
---|---|
0 | No laboratory tests performed |
1 | CBC, IgG/A/M |
2 | IgE, C3, C4, CH50, AH50, functional antibody response including to tetanus, polio, hepatitis B vaccine |
3 | Basic lymphocyte subset analysis (CD3, CD4, CD8, CD19, CD20, CD16, CD56), dihydrorhodamine test, nitroblue tetrazolium test |
4 | Lymphocyte cell marker CD45RO/RA, TREC qPCR, lymphocyte proliferation test, NK cytotoxicity studies |
5 | Comprehensive T or B cell subset with markers other than those mentioned in levels 3 and 4, protein expression of PID genes (e.g., WASP, BTK, CD40L by flow cytometry), assays of pathway activation (e.g., pSTAT3 by Western blot or flow cytometry), cytokine production (e.g., IFN-gamma level by ELISA) |
CBC, complete blood count, TREC, T-cell receptor excision circle; qPCR, quantitative polymerase chain reaction.